8299307772

14:00-17:00

i; i we? C5

II IMPLEMENTATION OF THE SAS EL STATEMENTS - COUNTRY AND REGIONAl ACTIONS. | THE EV!0‘ D4

lEADERSMIP IN PRACI1CE D5

| PHARM ACOGENETICS: PHARMAMSTS GfcT REAOY' (RO INOTA8I E) B2 SOCIAL, POLTT1CAL AND BIOLOGICAl ASPECTS OF ANTIMICROBIAL R ESI ST ANCE. AN NTEGRATED APPROACH G5

MN PHARM Ar INPnPMATT-.N l!'HN <    . IMPR:;vi PAII‘Nf . ł " -

<36

14:00-15:00

I PHARMACY ONLY MEDICINE CATEGORY BE THE BEST ALTERNATTOE? PERSPECTTVES I PROM DIPPERENT STAPEhC -DER> H2

WEDNE5DAY 1ST OF SEPTEMBER 2010

09:00-12:00 I african pharmaceuttcal forjm annual meeting H3 COM BAT1NG COU N TERFEIT M ED1CINES I G7

ENGAGING LEARNERS IN CONTINUING PROFESSIONAL OEVELOPMENT WORKSHOP ES

INFLUENZA A (H1N1) PANDEMIE; FACING THE GLOBAL CHAŁ LENGES F3 NANOMEOICINE: INTEGRATING NANOTECHNOLOGY IN HEALTHCARE C6

| TWE JOURNEY TOWARDS BETTBt OUTCOMES A3

■hi prac nii.)N- - 0AYID6

14:00-17:00    C7

rOMBATTNG CAUN TFRFFTT MFDICINFS 11 G8

to Ul t.    E8

atrriNG prom iiERi o tv A4

OPTIMISING OUTCOMES IN AN OPERATIONAL ENVIRONMENT F4 I PHARM ACISTS; AN UNTAPPED POTENT1AL IN TB CONTROL’ H6 'hi acnr: -•. ■    07

THURSDAY 2ND OF 09:00-12:00

SEPTEMBER 2010

BALANCING SAFFTY MANAGEMENT AND SUSTAINABLE INN3VATION. WHAT CAN PHARMA LEARN PROM OTHER INDUSTR" liy

COMPLH.N N PHARMA L-    - I :i ll?N> .--z:.' Lt-Ll N

11L) I E6

CURRENT ISSUES IN MtOICINE AND HEALTHCARE INFORMATION G10

LATEST UPDATES PROM FTP M EM BER ORGAN ISATIONS I H7

SYMPOSIIIM ON THF MISTORY OP PHARMACY I H4

THE NEED POR NEW ANTIBIOT1CS COMBATING RESISTANT BACTERIA C8

14:00-17:00

COMPETENCE IN PHARMACIES - THE ROLES OP INTERNSHIPS AND UFELONG

E7

LATEST UPDATES PROM PIP MEMBER ORGANISAT10NS II H8

PHARM ACISTS SERYING PATIENTS: